Insider: Lippoldt Darin Chief Legal Officer - NEUROCRINE BIOSCIENCES INC
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 43,405 | 0 | 43,405 |
| Value | $6,115,330.45 | $0.00 | $6,115,330.45 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 02/13/2025 | DDS | 1,086 | Direct | COM | $116.75 | $126,789.96 | 43,405 |
| 02/13/2025 | DDS | 1,098 | Direct | COM | $116.76 | $128,202.48 | 42,474 |
| 02/10/2025 | DDS | 911 | Direct | COM | $118.25 | $107,727.03 | 41,679 |
| 01/31/2025 | DDS | 1,250 | Direct | COM | $152.91 | $191,133.00 | 40,863 |
| 08/01/2024 | DDS | 2,996 | Direct | COM | $154.01 | $461,422.95 | 39,740 |
| 02/13/2024 | DDS | 1,098 | Direct | COM | $132.99 | $146,028.40 | 39,740 |
| 02/08/2024 | DDS | 911 | Direct | COM | $134.24 | $122,288.90 | 38,755 |
| 02/06/2024 | DDS | 1,041 | Direct | COM | $142.17 | $147,995.12 | 37,939 |
| 01/31/2024 | DDS | 1,250 | Direct | COM | $140.65 | $175,809.75 | 37,005 |
| 01/22/2024 | DDS | 10,000 | Direct | COM | $139.86 | $1,398,553.00 | 35,882 |
| 12/06/2023 | DDS | 20,830 | Direct | COM | $119.86 | $2,496,648.39 | 35,882 |
| 11/27/2023 | DDS | 10,919 | Direct | COM | $112.27 | $1,225,911.07 | 35,882 |
| 08/21/2023 | DDS | 2,132 | Direct | COM | $107.39 | $228,951.22 | 46,991 |
| 02/08/2023 | DDS | 911 | Direct | COM | $104.08 | $94,814.97 | 44,973 |
| 02/07/2023 | DDS | 1,522 | Direct | COM | $102.24 | $155,613.39 | 32,660 |
| 02/07/2023 | DDS | 12,801 | Direct | COM | $102.42 | $1,311,066.90 | 44,157 |
| 02/06/2023 | DDS | 1,041 | Direct | COM | $105.80 | $110,141.44 | 31,290 |
| 01/31/2023 | DDS | 1,250 | Direct | COM | $109.97 | $137,464.00 | 30,357 |
| 11/08/2022 | DDS | 5,082 | Direct | COM | $125.04 | $635,441.59 | 29,234 |
| 11/02/2022 | DDS | 400 | Direct | COM | $125.00 | $50,000.00 | 29,234 |
| 11/01/2022 | DDS | 10,000 | Direct | COM | $120.09 | $1,200,899.00 | 29,234 |
| 10/27/2022 | DDS | 4,923 | Direct | COM | $115.04 | $566,331.58 | 29,234 |
| 10/26/2022 | DDS | 5,077 | Direct | COM | $115.02 | $583,965.68 | 29,234 |
| 10/04/2022 | DDS | 10,000 | Direct | COM | $111.04 | $1,110,446.00 | 29,234 |
| 03/22/2022 | DDS | 8,455 | Direct | COM | $95.05 | $803,656.21 | 29,396 |
| 1 2 3 Next Last You are at page 1 of 3 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research